Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael

Showing results (961-970 of 1,001) with videos related to

Pageof 101
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 22, 2015
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trialBente L Langdahl, Christence Stubbe Teglbjærg, Pei-Ran Ho, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stabilityDonghong Amy Gao, Zhaoming Xiong, Alexander Heim-Riether, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®E Michael Lewiecki, Juliet E Compston, Paul D Miller, et al.
Blood|April 23, 2014
Inherited biallelic CSF3R mutations in severe congenital neutropeniaAlexa Triot, Päivi M Järvinen, Juan I Arostegui, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral densityEric Orwoll, Christence S Teglbjærg, Bente L Langdahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyMerav Bar, Susan M Ott, E Michael Lewiecki, et al.
Mayo Clinic Proceedings|December 3, 2025
Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best PracticesWillem F Lems, Kate A Ward, E Michael Lewiecki, et al.
The New England Journal of Medicine|November 6, 2009
Inflammatory bowel disease and mutations affecting the interleukin-10 receptorErik-Oliver Glocker, Daniel Kotlarz, Kaan Boztug, et al.
Molecular Cancer Therapeutics|August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
The Journal of Experimental Medicine|February 27, 2013
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndromeDaniel Kotlarz, Natalia Ziętara, Gulbu Uzel, et al.
Pageof 101

Showing results (961-970 of 1,001) with videos related to

Sort By:
Pageof 101
The Journal of Clinical Endocrinology and Metabolism|January 22, 2015
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trialBente L Langdahl, Christence Stubbe Teglbjærg, Pei-Ran Ho, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stabilityDonghong Amy Gao, Zhaoming Xiong, Alexander Heim-Riether, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®E Michael Lewiecki, Juliet E Compston, Paul D Miller, et al.
Blood|April 23, 2014
Inherited biallelic CSF3R mutations in severe congenital neutropeniaAlexa Triot, Päivi M Järvinen, Juan I Arostegui, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral densityEric Orwoll, Christence S Teglbjærg, Bente L Langdahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyMerav Bar, Susan M Ott, E Michael Lewiecki, et al.
Mayo Clinic Proceedings|December 3, 2025
Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best PracticesWillem F Lems, Kate A Ward, E Michael Lewiecki, et al.
The New England Journal of Medicine|November 6, 2009
Inflammatory bowel disease and mutations affecting the interleukin-10 receptorErik-Oliver Glocker, Daniel Kotlarz, Kaan Boztug, et al.
Molecular Cancer Therapeutics|August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
The Journal of Experimental Medicine|February 27, 2013
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndromeDaniel Kotlarz, Natalia Ziętara, Gulbu Uzel, et al.
Pageof 101